U.S. stocks retreated on Wednesday after two straight days of gains, as weakness in shares of Abbott Laboratories and Read More
Search
Newsletter
Stock Prices
Symbol | Last Price | Change | % Change |
---|---|---|---|
Investing News
- How To Switch Financial Advisors
- How Do You Shop for a Home Equity Loan?
- Top 5 Companies Owned by X Corp. (Formally Twitter, Inc.)
- How Tesla Makes Money: All-Electric Cars
- Steve Jobs’ 10 Most Innovative Creations
- New ETFs that combine bitcoin exposure and options are coming in 2025
- 6 Must-Know Tax Code Hacks for Savvy Filers
- The 6 U.S. Cities Where Your Paycheck Goes the Furthest
- 10 Ways to Improve Cash Flow
- Do Minimum Wage Laws Make Labor a Fixed or Variable Cost?
Stock Market
- Why The Honest Company’s Stock Swooned in December
- 2025 Is the Year of BATMMAAN. Artificial Intelligence (AI) Leader Nvidia Is the $1 Trillion Stock to Buy.
- Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical
- A Once-in-a-Decade Investment Opportunity: My Pick for the Best AI Stock to Buy in 2025
- Why Microsoft (MSFT) Outpaced the Stock Market Today
Stocks To Buy
- Why The Honest Company’s Stock Swooned in December
- 2025 Is the Year of BATMMAAN. Artificial Intelligence (AI) Leader Nvidia Is the $1 Trillion Stock to Buy.
- Zacks.com featured highlights include Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical
- A Once-in-a-Decade Investment Opportunity: My Pick for the Best AI Stock to Buy in 2025
- Why Microsoft (MSFT) Outpaced the Stock Market Today